Head of Board of Directors of Sanofi, Venberg said at the signing ceremony attended by President Rouhani and Foreign Minister Zarif and Minister of Health, Treatment and Medical Education Hassan Qazi Hashemi that no doubt, a new chapter in Iran-France ties has opened concurrent with the removal of anti-Iran sanctions.
He added that Sanofi as the biggest pharmaceutical multinational company in France will be committed to present innovative solutions and new treatment approaches during his presence in Iran.
As per the agreement, Sanof will seek ways to promote cooperation with the Iranian producers and make its experience in the fields of quality standards of medicine, technology of producing medicines available to them, he said.
Sanofi also intends to launch permanent and serious cooperation with Health Ministry in the projects to prevent and contain certain diseases, Venberg said.
Sanofi has studied ways of cooperation with Iran’s scientific community so that it will be able to transfer its knowledge in the field of epidemiologic studies to Iran, he said.
The main goal of the cooperation is management of improving chronic and non-contagious diseases such as diabetes and MS as well as rare diseases.
Sanofi started its activities officially in Tehran in 2006 following the establishment of a representative office in the capital.